Key Points
- Longitude Capital Partners II sold 49,000 shares of Rapid Micro Biosystems on Feb 4 at $3.88 and has disposed of a total of 130,239 shares across trades from Jan 23–Feb 4, generating roughly $547,255 in proceeds.
- RPID trades near $3.87 with a 12‑month range of $1.86–$4.94 and a market cap of about $171.5M; the company reports negative EPS/margins, yet analysts hold a consensus "Moderate Buy" with a $8.00 target.
Rapid Micro Biosystems, Inc. (NASDAQ:RPID - Get Free Report) major shareholder Longitude Capital Partners Ii, sold 49,000 shares of the company's stock in a transaction on Wednesday, February 4th. The stock was sold at an average price of $3.88, for a total transaction of $190,120.00. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Large shareholders that own more than 10% of a company's stock are required to disclose their sales and purchases with the SEC.
Longitude Capital Partners Ii, also recently made the following trade(s):
- On Monday, February 2nd, Longitude Capital Partners Ii, sold 27,500 shares of Rapid Micro Biosystems stock. The shares were sold at an average price of $4.25, for a total transaction of $116,875.00.
- On Friday, January 30th, Longitude Capital Partners Ii, sold 46,000 shares of Rapid Micro Biosystems stock. The shares were sold at an average price of $4.54, for a total transaction of $208,840.00.
- On Friday, January 23rd, Longitude Capital Partners Ii, sold 7,739 shares of Rapid Micro Biosystems stock. The shares were sold at an average price of $4.06, for a total value of $31,420.34.
Rapid Micro Biosystems Price Performance
NASDAQ:RPID opened at $3.87 on Friday. The business's 50-day moving average is $3.67 and its 200 day moving average is $3.40. Rapid Micro Biosystems, Inc. has a 12 month low of $1.86 and a 12 month high of $4.94. The company has a market capitalization of $171.52 million, a P/E ratio of -3.83 and a beta of 1.38. The company has a current ratio of 4.23, a quick ratio of 2.95 and a debt-to-equity ratio of 0.42.
Rapid Micro Biosystems (NASDAQ:RPID - Get Free Report) last released its quarterly earnings data on Friday, November 7th. The company reported ($0.26) earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of ($0.26). The business had revenue of $7.84 million for the quarter, compared to the consensus estimate of $7.60 million. Rapid Micro Biosystems had a negative return on equity of 73.90% and a negative net margin of 145.11%. On average, equities research analysts forecast that Rapid Micro Biosystems, Inc. will post -1.1 earnings per share for the current fiscal year.
Wall Street Analyst Weigh In
Several equities analysts have commented on RPID shares. Weiss Ratings reiterated a "sell (d-)" rating on shares of Rapid Micro Biosystems in a research report on Thursday, January 22nd. Wall Street Zen downgraded shares of Rapid Micro Biosystems from a "hold" rating to a "sell" rating in a report on Saturday, January 17th. One analyst has rated the stock with a Strong Buy rating, one has given a Buy rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, Rapid Micro Biosystems has a consensus rating of "Moderate Buy" and a consensus target price of $8.00.
Read Our Latest Stock Report on Rapid Micro Biosystems
Institutional Inflows and Outflows
Several large investors have recently modified their holdings of the business. Nano Cap New Millennium Growth Fund L P purchased a new stake in shares of Rapid Micro Biosystems in the fourth quarter worth approximately $72,000. Hudson Bay Capital Management LP purchased a new stake in Rapid Micro Biosystems in the third quarter worth $38,000. Susquehanna International Group LLP lifted its position in shares of Rapid Micro Biosystems by 12.6% during the third quarter. Susquehanna International Group LLP now owns 58,387 shares of the company's stock worth $195,000 after purchasing an additional 6,528 shares during the last quarter. Dimensional Fund Advisors LP boosted its stake in shares of Rapid Micro Biosystems by 37.8% during the third quarter. Dimensional Fund Advisors LP now owns 55,642 shares of the company's stock valued at $186,000 after purchasing an additional 15,255 shares during the period. Finally, Evernest Financial Advisors LLC grew its holdings in shares of Rapid Micro Biosystems by 355.1% in the third quarter. Evernest Financial Advisors LLC now owns 200,234 shares of the company's stock worth $669,000 after purchasing an additional 156,234 shares during the last quarter. Hedge funds and other institutional investors own 52.60% of the company's stock.
Rapid Micro Biosystems Company Profile
(
Get Free Report)
Rapid Micro Biosystems (NASDAQ: RPID) develops and commercializes automated microbial detection and contamination control solutions for the life sciences industry. Its flagship offering, the Growth Direct® System, leverages digital imaging and proprietary growth indicator plates to identify and count microorganisms more rapidly than traditional culture-based methods. The company's technology platform is designed to streamline quality control workflows in pharmaceutical, biotechnology and vaccine manufacturing settings, helping clients reduce release times and improve operational efficiency.
In addition to the Growth Direct® System, Rapid Micro Biosystems offers an integrated suite of software and consumables that support automated data capture, analysis and reporting.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
